IRIX – IRIDEX Corp.
IRIX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
0.48
Margin Of Safety %
Put/Call OI Ratio
0.1
EPS Next Q Diff
EPS Last/This Y
0.14
EPS This/Next Y
0.12
Price
1.05
Target Price
2.75
Analyst Recom
1
Performance Q
-27.27
Upside
-975.0%
Beta
0.65
Ticker: IRIX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-13 | IRIX | 1.02 | 0.29 | 0.00 | 261 |
| 2026-04-14 | IRIX | 1.03 | 0.29 | 0.00 | 261 |
| 2026-04-15 | IRIX | 1.03 | 0.29 | 0.00 | 261 |
| 2026-04-20 | IRIX | 1.06 | 0.12 | 0.00 | 208 |
| 2026-04-23 | IRIX | 1.045 | 0.11 | 0.00 | 234 |
| 2026-04-24 | IRIX | 1.06 | 0.11 | 0.00 | 234 |
| 2026-04-27 | IRIX | 1.08 | 0.11 | 0.00 | 234 |
| 2026-04-28 | IRIX | 1.04 | 0.11 | 0.00 | 234 |
| 2026-04-29 | IRIX | 1.03 | 0.11 | 0.00 | 234 |
| 2026-04-30 | IRIX | 1.03 | 0.11 | 0.00 | 234 |
| 2026-05-01 | IRIX | 1.04 | 0.10 | 0.00 | 244 |
| 2026-05-04 | IRIX | 1.095 | 0.10 | 0.00 | 244 |
| 2026-05-05 | IRIX | 1.055 | 0.10 | 0.00 | 245 |
| 2026-05-06 | IRIX | 1.04 | 0.10 | 0.00 | 245 |
| 2026-05-07 | IRIX | 1.04 | 0.10 | 0.00 | 245 |
| 2026-05-08 | IRIX | 1.03 | 0.10 | 0.00 | 245 |
| 2026-05-11 | IRIX | 1.04 | 0.10 | 0.00 | 245 |
| 2026-05-12 | IRIX | 1.05 | 0.10 | 0.00 | 245 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-13 | IRIX | 1.02 | - | - | -0.12 |
| 2026-04-14 | IRIX | 1.03 | - | - | -0.12 |
| 2026-04-15 | IRIX | 1.05 | - | - | -0.12 |
| 2026-04-16 | IRIX | 1.04 | - | - | -0.12 |
| 2026-04-17 | IRIX | 1.05 | - | - | -0.12 |
| 2026-04-20 | IRIX | 1.05 | - | - | -0.12 |
| 2026-04-21 | IRIX | 1.07 | - | - | -0.12 |
| 2026-04-22 | IRIX | 1.05 | - | - | -0.12 |
| 2026-04-23 | IRIX | 1.04 | - | - | -0.12 |
| 2026-04-24 | IRIX | 1.06 | - | - | -0.12 |
| 2026-04-27 | IRIX | 1.09 | - | - | -0.12 |
| 2026-04-28 | IRIX | 1.04 | - | - | -0.12 |
| 2026-04-30 | IRIX | 1.04 | - | - | -0.12 |
| 2026-05-01 | IRIX | 1.04 | - | - | -0.12 |
| 2026-05-04 | IRIX | 1.09 | - | - | -0.12 |
| 2026-05-05 | IRIX | 1.06 | - | - | -0.12 |
| 2026-05-06 | IRIX | 1.04 | - | - | -0.12 |
| 2026-05-07 | IRIX | 1.03 | - | - | -0.12 |
| 2026-05-08 | IRIX | 1.03 | - | - | -0.12 |
| 2026-05-11 | IRIX | 1.04 | - | - | -0.12 |
| 2026-05-12 | IRIX | 1.05 | - | - | -0.12 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-13 | IRIX | 2.03 | 2.79 | 0.28 |
| 2026-04-14 | IRIX | 2.03 | 2.79 | 0.28 |
| 2026-04-15 | IRIX | 2.03 | 2.79 | 0.28 |
| 2026-04-16 | IRIX | 2.03 | 2.79 | 0.28 |
| 2026-04-17 | IRIX | 2.03 | 2.79 | 0.28 |
| 2026-04-20 | IRIX | 2.03 | 2.79 | 0.28 |
| 2026-04-21 | IRIX | 2.03 | 2.79 | 0.28 |
| 2026-04-22 | IRIX | 2.03 | 2.79 | 0.28 |
| 2026-04-23 | IRIX | 2.00 | 2.79 | 0.28 |
| 2026-04-24 | IRIX | 2.00 | 2.79 | 0.28 |
| 2026-04-27 | IRIX | 2.00 | -0.33 | 0.90 |
| 2026-04-28 | IRIX | 2.00 | -0.33 | 0.90 |
| 2026-04-29 | IRIX | 2.00 | -0.33 | 0.90 |
| 2026-04-30 | IRIX | 1.99 | -0.33 | 0.89 |
| 2026-05-01 | IRIX | 1.99 | -0.33 | 0.89 |
| 2026-05-04 | IRIX | 1.99 | -0.10 | 0.89 |
| 2026-05-05 | IRIX | 1.99 | -0.10 | 0.89 |
| 2026-05-06 | IRIX | 1.99 | -0.10 | 0.89 |
| 2026-05-07 | IRIX | 1.99 | -0.10 | 0.89 |
| 2026-05-08 | IRIX | 1.99 | -0.10 | 0.89 |
| 2026-05-11 | IRIX | 1.99 | -0.10 | 0.89 |
| 2026-05-12 | IRIX | 1.99 | -0.10 | 0.48 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.05
Avg. EPS Est. Next Quarter
-0.02
Insider Transactions
1.99
Institutional Transactions
-0.1
Beta
0.65
Average Sales Estimate Current Quarter
13
Average Sales Estimate Next Quarter
14
Fair Value
Quality Score
21
Growth Score
37
Sentiment Score
59
Actual DrawDown %
88.9
Max Drawdown 5-Year %
-91.6
Target Price
2.75
P/E
Forward P/E
PEG
P/S
0.34
P/B
P/Free Cash Flow
EPS
-0.26
Average EPS Est. Cur. Y
-0.12
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-8.42
Relative Volume
0.11
Return on Equity vs Sector %
-117
Return on Equity vs Industry %
-101.9
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.05
EBIT Estimation
◆
IRIX
Healthcare
$1.04
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
44
Range 1M
42.9%
Sup Dist
0.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
53.9%
EPS NY
100%
52W%
22%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+164.4% upside
Upside
+164.4%
Quality
21
IRIDEX CorporationSector: Healthcare
Industry: Medical Devices
Employees:
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
IRIX
Latest News
—
Caricamento notizie per IRIX…
stock quote shares IRIX – IRIDEX Corp. Stock Price stock today
news today IRIX – IRIDEX Corp. stock forecast ,stock prediction 2023 2024 2025
marketwatch IRIX – IRIDEX Corp. yahoo finance google finance
stock history IRIX – IRIDEX Corp. invest stock market
stock prices IRIX premarket after hours
ticker IRIX fair value insiders trading